Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Bayer Agrees to Increased Payment of $2B To Settle Roundup Non-Hodgkins Lymphoma Cases Diagnosed Over Next Four Years February 4, 2021 Irvin Jackson Add Your Comments After a federal judge previously signaled that an attempt to bind individuals not yet diagnosed with non-Hodgkins lymphoma from Roundup to a class action settlement may not be proper or fair, Bayer has revised the deal and increased the compensation that it will pay to resolve cases diagnosed over the next four years. In June 2020, Bayer announced that it would spend more than $10 billion in Roundup settlements, which the manufacturer indicated would resolve most pending lawsuits filed by individuals diagnosed with non-Hodgkins lymphoma following exposure to the weedkiller, and included $1.25 billion set aside to address future claims. While individual settlements are moving forward for previously diagnosed and filed claims, the U.S. District Judge presiding over the federal litigation expressed skepticism about the “propriety and fairness” of a proposed class action settlement that would bind individuals not yet diagnosed with cancer, and limit their right to pursue lawsuits through the court system in the future. ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION ROUNDUP LAWSUITS Were you or a loved one exposed to RoundUp? Exposure to RoundUp has been linked to an increased risk of developing Non-Hodgkin’s Lymphoma and other cancers. RoundUp cancer lawsuits are being actively investigated. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As a result, the proposed Roundup class action settlement was withdrawn by the parties, and additional negotiations have been ongoing over the past six months. In a motion for preliminary approval (PDF) filed on February 3, the parties outlined the key features of a new proposal to settle Roundup non-Hodgkins lymphoma cases diagnosed in the future, including an increase in the total funding up to $2 billion and a resolution program where class members do not lose the right to file a lawsuit if they decide not to accept the amount awarded. “The present agreement has been rebuilt from the studs on up,” according to the 83 page proposal submitted by lawyers. “First, and foremost, the present agreement is based on conventional notions of claim resolution rather than issue preclusive determination. The new Settlement contains a straightforward compensation fund to make offers to class members who have or develop NHL, together with a broad program of diagnostic assistance for NHL risk and other programmatic benefits.” Key features include a compensation fund that will be optional for individuals diagnosed with non-Hodgkins lymphoma, providing awards that will range between $10,000 and $200,000 per person in exchange for a release. However, if they choose not to participate, future claimants maintain their right to file a Roundup lawsuit against Bayer and it’s Monsanto subsidiary. The program would also include free legal assistance and representation to help navigate and evaluate the settlement benefits, a diagnostic testing program and outreach efforts to bring users of Roundup into the diagnostic and compensation programs. Under terms of the Roundup settlement, Monsanto will also seek permission from the EPA to include information on the weedkiller label about the link between Roundup and non-Hodgkins lymphoma, as well as a link to information about whether exposure causes the cancer. Bayer has agreed to a 60% increase in the amount that will be paid to fund the settlement, with up to $2 billion in payments over the first four years. After this initial period expires, the parties may seek to extend the settlement, with additional funding provided above the initial $2 billion. Tags: Bayer, Cancer, Herbicide, Monsanto, Non-Hodgkins Lymphoma, Roundup, Weed Killer Image Credit: Photo Courtesy of <a href="https://www.flickr.com/photos/jeepersmedia/14874003257/in/photolist-oEn9Y2-oEmvHy-bTWHFx-nfCdLV-r4HEKx-rnWS2S-r6sFqE-p2qQKx-oZp21Q-p2arLx-oZoYWu-p2qRNe-oZp1K9-oWzFf8-oJWeBo-oWPq8C-p2oWDC-oJWGji-oEmb2Z-oWRdiz-GJW4pR-GGDZ27-a9RCv2-qrg4mF-rnV1kP-fwZmz-2sscR9-oe3oMa-sboouE-7Q9sz-auohod-rbkbaM-dykaWR-HadKLC-rnUQ6F-r4HT7B-rkKbUm-qr3DSm-qr3t6G-r6sNDC-qr3A3h-9Kvo44-5XtM3N-ey91rF-oe3ovi-8XXkwu-odYLgh-nWy2oy-ofPpbP-odSXiw">Mike Mozart via Flickr</a> Creative Commons More Roundup Lawsuit Stories New Study Appears To Confirm Link Between Roundup and Cancer July 7, 2025 U.S. Supreme Court Invites Government To Weigh In on Roundup Cancer Lawsuits July 1, 2025 Roundup Lawsuit Payout of $611M Upheld by Appeals Court May 29, 2025 1 Comments Marilyn March 19, 2021 My husband has Parkinsons! He has always taken care of our yard using roundup from around 1984 untill 2019. He was healthy for the most part. In 2013 he was diagnosed with Parkinsons disease and he is in horrible health. He was not even 50 years old when he got Parkinsons and now he is not able to work or do much of anything. We have been married for 37 years and Parkinsons has taken so much from us. I’ve always known it had to be some type of chemical that caused this disease. Now we have fou.d out he had a tumor on his liver! At this time we have not had any tests ran on his liver. I weep as I watch this disease destroy my husband day by day. We not only struggle with this awful disease but we stuggle mentally, and financially! Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025) Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025) Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)
Oxbryta Settlement Discussions in Class Action Lawsuits Set for Sept. 2025 (Posted: today) A mediator has been appointed to oversee settlement discussions between parties involved in an Oxbryta class action lawsuit, which claims the recalled drug endangered sickle cell disease patients. MORE ABOUT: OXBRYTA LAWSUITWrongful Death Lawsuit Links Oxbryta Side Effects to Deadly Vaso-Occlusive Crises (06/05/2025)Oxbryta Recall Lawsuit Alleges Sickle Cell Drug Increased Frequency of Dangerous VOCs (05/23/2025)First Oxbryta Lawsuit Set for Trial in August 2027, Over Recalled Sickle Cell Drug Risks (05/09/2025)
Lawsuit Indicates Biozorb Side Effects Left Woman With Chronic Pain, Disfiguring Injuries (Posted: yesterday) A BioZorb side effects lawsuit indicates that a woman is suffering chronic pain and soreness after the tissue marker implant failed to absorb into her body as advertised. MORE ABOUT: BIOZORB LAWSUITBioZorb Implant Removal Surgery: What Women Need To Know When the Device Fails To Dissolve (06/30/2025)Lawsuit Claims Biozorb Implant Penetrated Skin, Causing Massive Infection (06/04/2025)Breast Cancer Survivors File BioZorb Tissue Marker Lawsuit After Implant Fails (05/20/2025)
Second Wave of Valsartan Cancer Lawsuits To Be Ready for Bellwether Trials by January 2026 (Posted: 2 days ago) A new schedule for a second wave of Valsartan cancer lawsuit bellwether trials hopes to have a case ready to go before a jury by January 2026. MORE ABOUT: VALSARTAN LAWSUITCourt Outlines Valsartan Lawsuits Trial Schedule for “Wave 2” Bellwether Cases (05/28/2025)Order Requires Valsartan Recall Lawsuits To Provide Product Identification for Specific Generic Drug Makers Named (03/27/2025)Deadlines Leading to First Valsartan Bellwether Trial on Sept. 8, 2025 Outlined by Special Master (03/04/2025)